Preprint
Article

This version is not peer-reviewed.

Effects of Secondhand Exposure to Heated Tobacco Products on Human Milk Composition

Submitted:

22 May 2026

Posted:

22 May 2026

You are already at the latest version

Abstract
Background: Secondhand exposure to heated tobacco products (HTPs) is increasingly common, but its impact on human milk composition is unclear. We investigated whether secondhand exposure to HTP aerosols affects major human milk components and cotinine concentrations in lactating women. Methods: This observational study included 15 lactating women whose household members used HTPs (secondhand HTP exposure group) and 33 lactating women who did not live with any smokers (non-exposed group). Human milk was analyzed for macronutrients, total solids, energy, lactoferrin, secretory immunoglobulin A (sIgA), calcium, inorganic phosphorus, zinc, and cotinine. Cotinine was measured in all exposed women and in three women in the non-exposed group. Results: Background characteristics did not differ significantly between groups. No significant differences were observed in lipid, protein, total solids, energy, true protein, lactoferrin, calcium, inorganic phosphorus, or zinc. Carbohydrate concentration differed significantly between the non-exposed and secondhand exposure groups (non-exposed vs. secondhand HTP exposure: 8.20 vs. 8.10 g/dL, p = 0.032). sIgA tended to be higher in the secondhand HTP exposure group (non-exposed vs. secondhand HTP exposure: 1,244 vs. 1,706 μg/mL, p = 0.072). Cotinine concentrations did not differ significantly between groups; qualitative cotinine tests were negative in all samples. Conclusion: In this study, secondhand exposure to HTPs was not associated with clear changes in major human milk components or cotinine concentrations. While secondhand exposure should be avoided whenever possible, these findings suggest that household members’ use of HTPs does not justify refraining from breastfeeding.
Keywords: 
;  ;  ;  ;  

1. Introduction

Cigarette smoke contains more than 4,000 chemical compounds, including nicotine, and over 60 known carcinogens [1]. Exposure to secondhand tobacco smoke has been shown to adversely affect the health and development of fetuses and infants [2,3,4]. Nevertheless, many women continue to be exposed to secondhand smoke through their partners or living environments. In Japan, around 40% of pregnant women are exposed to secondhand smoke in some form, with reported exposure frequencies of 23.7% for 1–3 days per week and 15.8% for 4–7 days per week in indoor environments such as the home, workplace, and other enclosed settings [5].
In recent years, the use of heated tobacco products (HTPs) has increased, driven by the widespread perception that they are less harmful to health than conventional cigarettes [6,7]. HTPs are devices in which tobacco leaves or reconstituted tobacco products are inserted into a dedicated holder and electrically heated to generate an inhalable aerosol. According to the National Health and Nutrition Survey in Japan (2019), 20–30% of current smokers use HTPs. The nicotine content of HTP aerosols has been reported to be comparable to, or slightly lower than, that of conventional cigarettes [8,9]. Although HTP aerosols contain multiple toxic and harmful chemicals at concentrations considered lower than those in conventional cigarette smoke, several studies suggest that the health risks associated with HTPs may be comparable to those of conventional cigarettes [9,10].
Breastfeeding plays a fundamental role in the healthy growth and development of infants. Studies have shown that when lactating women are exposed to tobacco smoke, nicotine and other chemicals, including carcinogens, pass into human milk [11,12]. Nicotine has been shown to suppress prolactin secretion and the milk ejection reflex, thereby reducing milk production and shortening the duration of breastfeeding [13]. The altered taste of human milk due to nicotine exposure may cause some infants to refuse feeding [13]. Furthermore, maternal smoking during lactation has been reported to alter the composition of human milk, including reduced lipid, energy, and protein concentrations, as well as decreased antioxidant capacity and iodine content [14,15]. Even when mothers themselves do not smoke, exposure to secondhand smoke from smokers in the household has been associated with reduced lipid and protein levels in human milk [11,16].
However, the impact of secondhand exposure to HTP aerosols on human milk composition remains unclear. In this study, we investigated the effects of secondhand exposure to HTPs on human milk composition and additionally measured cotinine concentrations in human milk, as cotinine is the major metabolite of nicotine.

2. Materials and Methods

Participants were recruited using a study poster to invite eligible lactating women to participate. The secondhand exposure group consisted of 15 lactating women whose household members used HTPs. The non-exposed group consisted of 33 lactating women who did not live with any smokers; this group included 30 human milk bank donors whose donated milk to The Nippon Foundation Human Milk Bank (TNFHMB) had been consented for research use and 3 lactating women recruited via the study poster for the present study. This study was approved by the Showa Medical University Research Ethics Review Board (approval number: 22-141-B).
Human milk samples were stored at −30 °C until analysis. Before analysis, frozen samples were shipped to TNFHMB and thawed in a refrigerator. The concentrations of lipid, protein, carbohydrate, total solids, energy, and true protein in human milk were measured using a Miris Human Milk Analyzer (Miris AB, Uppsala, Sweden), which uses infrared spectroscopy to quantify milk macronutrients and energy content. Daily quality control (including calibration checks and cleaning) was performed prior to sample analysis using the Miris Calibration Control Kit, Miris Check, and Miris Cleaner (Miris AB). Samples were warmed to 40 °C, sonicated, and then analyzed. As demonstrated in previous studies, this analyzer provides acceptable agreement with reference methods for the measurement of human milk macronutrients [17,18,19].
The concentrations of lactoferrin (LF), calcium (Ca), inorganic phosphorus (IP), and zinc (Zn) in human milk were measured as previously described [20,21]. LF levels were determined by a latex agglutination assay using Latex Test BL Lactoferrin (Biolinks, Kanagawa, Japan) after 100-fold dilution with the supplied diluent and were measured using a CA-270 Clinical Chemistry Analyzer (Furuno Electric, Hyogo, Japan) [20]. Ca, IP, and Zn were determined by colorimetric assays using Accuras Auto Ca II, Accuras Auto IP, and Accuras Auto Zn (Shino-Test, Tokyo, Japan), respectively. Milk samples were diluted 5-fold with the supplied diluent and measured using the CA-270 Clinical Chemistry Analyzer [21].
Secretory immunoglobulin A (sIgA) was measured by an enzyme-linked immunosorbent assay (ELISA). Samples were centrifuged to separate the fat layer, and the lower aqueous phase was collected for analysis. The concentrations of sIgA were measured using a Secretory Immunoglobulin A ELISA Kit (Immunodiagnostik, Bensheim, Germany).
For the determination of cotinine concentrations, human milk was collected on cotton swabs, stored frozen, and then sent to Kanematsu Wellness Co. (Tokyo, Japan), where cotinine was measured by ELISA. Donated milk from TNFHMB was not used for cotinine measurement; therefore, for cotinine analysis, the non-exposed group comprised three women. For qualitative cotinine testing, the cutoff value for positivity was 10 ng/mL.
Statistical analyses were performed using JMP Pro version 17 (SAS Institute Inc., Cary, NC, USA). Group comparisons were performed using the Mann–Whitney U test, with the significance level set at p < 0.05. All data are presented as medians.

3. Results

In the secondhand HTP exposure group, the most common daily number of HTP sticks smoked by household members was 10–19 (41%), followed by ≥20 (33%) and ≤10 (26%). The main locations for smoking were outdoors (e.g., on a balcony) in 46% of cases, in the same room as the mother in 27%, and in a different room within the home in 27%. Background characteristics of the non-exposed and secondhand exposure groups are presented in Table 1. There were no significant differences between the non-exposed and secondhand HTP exposure groups in gestational age at delivery (38.0 vs. 39.0 weeks, p = 0.24), postpartum week at the time of milk expression (17.0 vs. 16.0 weeks, p = 0.76), maternal age (34.0 vs. 31.0 years, p = 0.19), birth weight (3,085 vs. 3,074 g, p = 0.93), or parity (2.0 vs. 1.0, p = 0.17).
Human milk composition is shown in Table 2. There were no significant differences between the non-exposed and secondhand HTP exposure groups in median concentrations of lipid (3.20 vs. 3.90 g/dL, p = 0.48), protein (1.10 vs. 1.00 g/dL, p = 0.41), total solids (12.8 vs. 13.1%, p = 0.44), energy (68.0 vs. 72.0 kcal/dL, p = 0.39), or true protein (0.90 vs. 0.80 g/dL, p = 0.97). Carbohydrate concentration differed significantly between the non-exposed and secondhand. HTP exposure groups (8.20 vs. 8.10 g/dL, p = 0.032).
There were no significant differences between the two groups in lactoferrin (1,349 vs. 1,377 μg/mL, p = 0.53), calcium (30.4 vs. 28.0 mg/dL, p = 0.63), inorganic phosphorus (5.35 vs. 5.20 mg/dL, p = 0.74), or zinc (128.0 vs. 129.0 μg/dL, p = 0.69). Although the difference did not reach statistical significance, sIgA tended to be higher in the secondhand exposure group (1,244 vs. 1,706 μg/mL, p = 0.072).
With respect to cotinine concentrations, there was no significant difference between the non-exposed group and secondhand HTP exposure group (3.1 vs. 3.4 ng/mL, p = 0.37). Within the secondhand HTP exposure group, cotinine concentrations did not differ significantly between women whose household members smoked in the same room and those whose household members smoked in a different area (3.4 vs. 3.3 ng/mL, p = 0.54). Qualitative cotinine tests were negative in all samples.

4. Discussion

In this study, we examined the impact of secondhand exposure to HTPs on human milk composition and cotinine concentrations. Although a statistically significant difference in carbohydrate concentration was observed between the secondhand exposure and non-exposed groups, carbohydrate concentration was slightly lower in the secondhand HTP exposure group by 0.10g/dL (8.20 vs. 8.10 g/dL; p = 0.032). This finding should be interpreted with caution given the number of comparisons performed, as it may reflect a type I error. Lactose, the main carbohydrate in human milk, contributes to the osmotic pressure of milk and serves as a major energy source for infants [22]. However, the difference observed in this study is expected to have only a limited impact on infant growth and development.
The immune-related component sIgA tended to be higher in the secondhand HTP exposure group, although this difference did not reach statistical significance (p = 0.079). sIgA is a major immune factor in human milk that contributes to mucosal defense and can limit bacterial translocation through the infant gut mucosa [23]. Previous studies have reported that sIgA concentrations in the milk of smoking mothers were approximately 27% lower than those in non-smokers, although the difference did not reach statistical significance [24]. Conversely, other reports have found higher sIgA concentrations in the milk of mothers with a history of smoking [25], suggesting that the association between smoking-related exposure and milk sIgA concentrations may not be uniform. Because immune-related milk components can be influenced by maternal physiological and inflammatory conditions, and smoking-related exposure has been linked to oxidative stress and reduced antioxidant capacity [26], these factors may contribute to variability in milk sIgA. Larger studies with more detailed exposure assessment will be needed to determine whether secondhand exposure to HTP aerosols is associated with meaningful changes in immune-related components of human milk.
Research investigating the effects of secondhand exposure to aerosols from HTPs or electronic cigarettes on human milk composition is extremely limited. In animal experiments, Al-Sawalha et al. exposed lactating rats to e-cigarette aerosols for 1 hour daily from postnatal day 4 through day 20 [27]. Maternal exposure during lactation was associated with reduced milk fat content and lower maternal serum leptin levels compared with controls, whereas milk protein and lactose concentrations did not differ markedly. Offspring nursed by exposed dams also exhibited metabolic and endocrine alterations, including higher blood glucose and lower insulin levels. These findings suggest that exposure to e-cigarette aerosols during lactation may influence not only milk lipid content but also metabolic and hormonal profiles in both mothers and offspring.
In humans, secondhand exposure to electronic cigarettes has been described in a report by Ballbè et al [28]. In that report, cotinine was detected in the milk of a mother living with an electronic cigarette user, suggesting that nicotine can, in practice, be transferred to infants via human milk as a result of secondhand exposure.
In contrast to these reports, our study did not detect significant differences in lipid, other major components of human milk, or in cotinine concentrations. Several factors may account for these discrepancies, including differences in exposure intensity, environmental conditions, and product characteristics. In our study, most household members in the secondhand exposure group smoked outdoors, and exposure in the same room as the mother occurred in less than 30% of cases, whereas the experiment by Al-Sawalha et al. involved forced exposure in an enclosed space. In addition, all qualitative cotinine tests were negative in the secondhand exposure group, suggesting that the overall level of exposure was relatively low. Although the interval between the most recent secondhand exposure and milk collection was not recorded, cotinine has a relatively long half-life (approximately 6-30 h) [29]. In addition, cotinine concentrations in human milk exhibit less diurnal variation than nicotine and remain relatively stable over a 24 h period [29]. Therefore, the lack of precise information on the timing of the last exposure is unlikely to have materially affected the present findings. Moreover, the studies by Al-Sawalha et al. [27] and Ballbè et al. [28] focused on electronic cigarettes, whereas our study examined HTPs, which differ from electronic cigarettes in heating mechanisms and aerosol constituents. These differences in exposure conditions and product characteristics may partly explain the inconsistent findings among studies.

5. Limitations

This study has several limitations. First, the sample size was relatively small (n = 48), which may have limited the statistical power to detect modest differences between groups. In addition, the sample size for cotinine analysis in the non-exposed group was very small (n = 3), which limits the interpretability of between-group comparisons of cotinine concentrations. Second, secondhand exposure was assessed solely based on self-reported information regarding household members’ use of HTPs, without objective measurement of environmental nicotine concentrations or biomarkers of exposure in maternal blood or urine. We did not quantify actual exposure intensity, such as airborne particulate matter, room ventilation conditions, frequency and duration of exposure. Therefore, misclassification of exposure status cannot be excluded. In particular, some women classified as non-exposed may have experienced low-level environmental exposure outside the home, and conversely, women in the secondhand exposure group may have had minimal effective exposure if smoking occurred primarily outdoors. The absence of objective exposure assessment substantially limits our ability to evaluate dose–response relationships and may have attenuated potential differences between groups. Third, detailed information on patterns of HTP use and product characteristics (e.g., heating temperature, frequency of puffing, and specific product brands) was not collected, and individual differences in exposure intensity may therefore have influenced the results. In addition, as this was an observational study, it should be noted that it does not directly demonstrate a causal relationship between secondhand exposure to HTPs and changes in human milk composition.

6. Conclusions

In this study, we examined the effects of secondhand exposure to HTPs on major human milk components and cotinine concentrations. Although previous studies have reported decreases in several human milk components in association with secondhand exposure to conventional cigarette smoke, we did not observe significant differences in protein, lipid, or other major milk components between the secondhand exposure and non-exposed groups. Nonetheless, previous studies have demonstrated adverse effects associated with secondhand exposure to electronic cigarettes and HTPs, and it remains desirable for household members to refrain from using these products during the lactation period. At the same time, the immunological and nutritional benefits of breastfeeding are substantial, and secondhand exposure to HTP aerosols alone should not be regarded as a reason to refrain from breastfeeding. Future studies incorporating more detailed exposure assessment and long-term follow-up of maternal and infant outcomes are needed to clarify the effects of secondhand exposure to HTPs on human milk and child health.

Author Contributions

Conceptualization, M.Tareno and K.M.; Data curation, M.Tareno and K.M.; Investigation, M.Tateno., M.D., and M.Tanaka.; Project administration, K.M.; writing—original draft preparation, M.Tareno ; writing—review and editing, K.M. and M.Tanaka.;.

Funding

This research received no external funding

Institutional Review Board Statement

This study was approved by the Showa Medical University Research Ethics Review Board (approval number: 22-141-B).

Data Availability Statement

The raw data supporting the conclusions of this article will be made available by the authors on request.

Acknowledgments

The authors thank all mothers who participated in this study and generously provided human milk samples. The authors also thank Kanematsu Wellness Co. (Tokyo, Japan) for measuring human milk cotinine concentrations.

Conflicts of Interest

The authors declare no conflicts of interest.

Abbreviations

The following abbreviations are used in this manuscript:
HTPs Heated tobacco products
TNFHMB The Nippon Foundation Human Milk Bank
sIgA Secretory immunoglobulin A
ELISA Enzyme-linked immunosorbent assay

References

  1. Richter, P.; Pechacek, T.; Swahn, M.; Wagman, V. Reducing levels of toxic chemicals in cigarette smoke: a new Healthy People 2010 objective. Public Health Rep. 2008, 123(1), 30–38. [Google Scholar] [CrossRef] [PubMed]
  2. Leonardi-Bee, J.; Britton, J.; Venn, A. Secondhand smoke and adverse fetal outcomes in nonsmoking pregnant women: a meta-analysis. Pediatrics 2011, 127(4), 734–741. [Google Scholar] [CrossRef]
  3. Hashimoto, K.; Maeda, H.; Iwasa, H.; et al. Tobacco Exposure During Pregnancy and Infections in Infants up to 1 Year of Age: The Japan Environment and Children's Study. J. Epidemiol. 2023, 33(10), 489–497. [Google Scholar] [CrossRef]
  4. Mojibyan, M.; Karimi, M.; Bidaki, R.; Rafiee, P.; Zare, A. Exposure to Second-hand Smoke During Pregnancy and Preterm Delivery. Int. J. High Risk Behav. Addict 2013, 1(4), 149–153. [Google Scholar] [CrossRef]
  5. Tanaka, K.; Nishigori, H.; Watanabe, Z.; et al. Secondhand smoke exposure is associated with the risk of hypertensive disorders of pregnancy: the Japan Environment and Children's Study. Hypertens. Res. 2023, 46(4), 834–844. [Google Scholar] [CrossRef]
  6. Odani, S.; Tabuchi, T. Prevalence of heated tobacco product use in Japan: the 2020 JASTIS study. Tob. Control 2022, 31(e1), e64–e65. [Google Scholar] [CrossRef] [PubMed]
  7. Wężyk-Caba, I.; Kaleta, D.; Zajdel, R.; Balwicki, Ł.; Świątkowska, B. Do Young People Perceive E-Cigarettes and Heated Tobacco as Less Harmful Than Traditional Cigarettes? A Survey from Poland. Int. J. Environ. Res. Public Health Published. 2022, 19(22), 14632. [Google Scholar] [CrossRef]
  8. Farsalinos, K.E.; Yannovits, N.; Sarri, T.; Voudris, V.; Poulas, K. Nicotine Delivery to the Aerosol of a Heat-Not-Burn Tobacco Product: Comparison With a Tobacco Cigarette and E-Cigarettes. Nicotine Tob. Res. 2018, 20(8), 1004–1009. [Google Scholar] [CrossRef]
  9. Bekki, K.; Inaba, Y.; Uchiyama, S.; Kunugita, N. Comparison of Chemicals in Mainstream Smoke in Heat-not-burn Tobacco and Combustion Cigarettes. J. UOEH 2017, 39(3), 201–207. [Google Scholar] [CrossRef] [PubMed]
  10. Mallock, N.; Pieper, E.; Hutzler, C.; Henkler-Stephani, F.; Luch, A. Heated Tobacco Products: A Review of Current Knowledge and Initial Assessments. Front Public Health Published. 2019, 7, 287. [Google Scholar] [CrossRef]
  11. Shamsi, A.; Baheiraei, A.; Khaghani, S.; Mohsenifar, A.; Kazemnejad, A. The Reduction of Maternal Milk Proteins in Mothers Exposed to Passive Smoking: A Prospective Cohort Study. Women’s Health Bull. 2015, 2(2), 1–4. [Google Scholar] [CrossRef]
  12. Becker, A.B.; Manfreda, J.; Ferguson, A.C.; Dimich-Ward, H.; Watson, W.T.; Chan-Yeung, M. Breast-feeding and environmental tobacco smoke exposure. Arch. Pediatr. Adolesc. Med. 1999, 153(7), 689–691. [Google Scholar] [CrossRef]
  13. Vlachou, M.; Kyrkou, G.A.; Vivilaki, V.; et al. Tobacco Smoke Exposure and Lactation. Cureus Published. 2024, 16(11), e73651. [Google Scholar] [CrossRef]
  14. Macchi, M.; Bambini, L.; Franceschini, S.; Alexa, I.D.; Agostoni, C. The effect of tobacco smoking during pregnancy and breastfeeding on human milk composition-a systematic review. Eur. J. Clin. Nutr. 2021, 75(5), 736–747. [Google Scholar] [CrossRef] [PubMed]
  15. Laurberg, P.; Nøhr, S.B.; Pedersen, K.M.; Fuglsang, E. Iodine nutrition in breast-fed infants is impaired by maternal smoking. J. Clin. Endocrinol. Metab. 2004, 89(1), 181–187. [Google Scholar] [CrossRef] [PubMed]
  16. Baheiraei, A.; Shamsi, A.; Khaghani, S.; et al. The effects of maternal passive smoking on maternal milk lipid. Acta Med. Iran. 2014, 52(4), 280–285. [Google Scholar]
  17. Menjo, A.; Mizuno, K.; Murase, M.; et al. Bedside analysis of human milk for adjustable nutrition strategy. Acta Paediatr. 2009, 98(2), 380–384. [Google Scholar] [CrossRef]
  18. Navarro-Tapia, E.; Herranz Barbero, A.; Marquina, M.; et al. Comparative analysis of different methods for protein quantification in donated human milk. Front Pediatr. Published. 2024, 12, 1436885. [Google Scholar] [CrossRef]
  19. Borràs-Novell, C.; Herranz Barbero, A.; Aldecoa-Bilbao, V.; et al. Infrared analyzers for the measurement of breastmilk macronutrient content in the clinical setting. Expert Rev. Mol. Diagn. 2020, 20(9), 867–887. [Google Scholar] [CrossRef]
  20. Tanaka, M.; Date, M.; Mizuno, K. New latex agglutination assay for the determination of lactoferrin in human milk. Int. Breastfeed. J. Published. 2024, 19(1), 74. [Google Scholar] [CrossRef] [PubMed]
  21. Tanaka, M.; Mochida, M.; Date, M.; Mizuno, K. A Rapid Colorimetric Method for Determining Calcium, Inorganic Phosphorus, and Zinc in Human Milk Using Clinical Laboratory Reagents. J. Clin. Lab Anal. 2026, 40(2), e70146. [Google Scholar] [CrossRef]
  22. Cheema, A.S.; Stinson, L.F.; Rea, A.; et al. Human Milk Lactose, Insulin, and Glucose Relative to Infant Body Composition during Exclusive Breastfeeding. Nutrients Published. 2021, 13(11), 3724. [Google Scholar] [CrossRef]
  23. Hanson, L.A.; Korotkova, M. The role of breastfeeding in prevention of neonatal infection. Semin Neonatol. 2002, 7(4), 275–281. [Google Scholar] [CrossRef] [PubMed]
  24. Bachour, P.; Yafawi, R.; Jaber, F.; Choueiri, E.; Abdel-Razzak, Z. Effects of smoking, mother's age, body mass index, and parity number on lipid, protein, and secretory immunoglobulin A concentrations of human milk. Breastfeed. Med. 2012, 7(3), 179–188. [Google Scholar] [CrossRef] [PubMed]
  25. Groer, M.; Davis, M.; Steele, K. Associations between human milk SIgA and maternal immune, infectious, endocrine, and stress variables. J. Hum. Lact. 2004, 20(2), 153–163. [Google Scholar] [CrossRef] [PubMed]
  26. Napierala, M.; Merritt, T.A.; Miechowicz, I.; Mielnik, K.; Mazela, J.; Florek, E. The effect of maternal tobacco smoking and second-hand tobacco smoke exposure on human milk oxidant-antioxidant status. Environ. Res. 2019, 170, 110–121. [Google Scholar] [CrossRef]
  27. Al-Sawalha, N.A.; Bdeir, R.; Sohaib, A.; et al. Effect of E-cigarettes aerosol exposure during lactation in rats: Hormonal and biochemical aspects. Environ. Toxicol. Pharmacol. 2021, 88, 103759. [Google Scholar] [CrossRef]
  28. Ballbè, M.; Fu, M.; Masana, G.; et al. Passive exposure to electronic cigarette aerosol in pregnancy: A case study of a family. Environ. Res. 2023, 216 Pt 1, 114490. [Google Scholar] [CrossRef]
  29. Luck, W.; Nau, H. Nicotine and cotinine concentrations in the milk of smoking mothers: influence of cigarette consumption and diurnal variation. Eur. J. Pediatr. 1987, 146(1), 21–26. [Google Scholar] [CrossRef]
Table 1. Characteristics of the study participants.
Table 1. Characteristics of the study participants.
Non-exposed group
N=33
Secondhand exposure group
N=15
p-value
Gestational age at delivery
(weeks)
38.0 (38.0–40.0) 39.0 (38.0–40.0) 0.24
Postpartum week at milk expression
(weeks)
17.0 (12.0–24.0) 16.0 (9.5–28.0) 0.76
Maternal age at milk expression
(ages)
34.0 (31.0–36.0) 31.0 (29.0–34.5) 0.19
Birth weight (g) 3,085 (2,630–3,310) 3,074 (2,861–3,136) 0.93
Parity 2.0 (1.0–3.0) 1.0 (1.0–2.0) 0.17
Data are expressed as the median (interquartile range).
Table 2. Human milk composition in the non-exposed and secondhand exposure groups.
Table 2. Human milk composition in the non-exposed and secondhand exposure groups.
Non-exposed group
(n = 33)
Secondhand exposure group
(n = 15)
p-value
Lipid (g/dL) 3.20 (2.30–4.30) 3.90 (2.65–5.35) 0.48
Protein (g/dL) 1.10 (0.90–1.20) 1.00 (1.00–1.25) 0.41
Carbohydrate (g/dL) 8.20 (8.10–8.30) 8.10 (8.00–8.15) 0.032
Total solids (%) 12.8 (11.6–13.5) 13.1 (12.4–14.5) 0.44
Energy (kcal/dL) 68.0 (57.0–75.0) 72.0 (63.0–85.5) 0.39
True protein (g/dL) 0.90 (0.80–1.00) 0.80 (0.80–1.00) 0.97
Lactoferrin (μg/mL) 1,349 (1,095–1,578) 1,377 (1,101–1,896) 0.53
sIgA (μg/mL) 1,244(1,099–1,591) 1,706 (1,272–2,043) 0.072
Ca(mg/dL) 30.4 (26.0–32.7) 28.0 (26.5–32.4) 0.63
IP (mg/dL) 5.35(4.90–5.55) 5.20 (4.53–5.98) 0.74
Zn (μg/dL) 128.0 (74.0–181.0) 129.0 (80.5–222.0) 0.69
Data are expressed as the median (interquartile range).
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.
Prerpints.org logo

Preprints.org is a free preprint server supported by MDPI in Basel, Switzerland.

Subscribe

Accessibility

Disclaimer

Terms of Use

Privacy Policy

Privacy Settings

© 2026 MDPI (Basel, Switzerland) unless otherwise stated